Learn More
Description
- formulated with purified, intact virus particles that have been chemically modified to render them noninfectious and refrigerator stable
- Supplied in a purified protein matrix that mimics the composition of a true clinical specimen
- Contains 7 x 1mL vials
- Panel members:
- Influenza A H1, strain A/New Caledonia/20/99
- Influenza A H3, strain A/Brisbane/10/07
- Influenza A 2009 H1N1, strain NY/02/09
- Influenza B, strain B/Florida/02/06
- Respiratory Syncytial Virus A
- Respiratory Syncytial Virus B, strain CH93(18)-18
- Negative
NATFVP-NNS contains intact organisms and should be run in a manner identical to that used for clinical specimens.
Validation of clinical assays, development of diagnostic tests and training of laboratory personnel
Specifications
Specifications
| Certifications/Compliance | ISO, 13485 |
| Content And Storage | 2°C to 8°C |
| Form | Solution |
| Media Type | Vial |
| Product Type | NATtrol Verification Panel |
| For Use With (Application) | Determination of presence of viral Nucleic Acids |
| Quantity | 7 x 0.5 mL |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
